In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute